Company Filing History:

6 out of 119

Ucb S.a.

Years Active: 2004-2011

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8034958 - 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses (2011-10-11),

2. 7863450 - Compounds comprising an oxazoline or thiazoline moiety, processes for making them, and their uses (2011-01-04),

3. 7692028 - 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses (2010-04-06),

4. 7544675 - Chemical compounds with dual activity, processes for their preparation and pharmaceutical compositions (2009-06-09),

5. 7361668 - Quinuclidine derivatives processes for preparing them and their uses as m2 and/or m3 muscarinic receptor inhibitors (2008-04-22),

6. 7358276 - 2-Oxo-1-pyrrolidine derivatives, processes for preparing them and their uses (2008-04-15),

7. 6911461 - 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses (2005-06-28),

8. 6806287 - 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses (2004-10-19),

9. 6784197 - 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses (2004-08-31),

Title: **Patrice Talaga: Innovator in Neurological Pharmaceutical Development**

Introduction

Patrice Talaga is a distinguished inventor based in Watermael-Boitsfort, Belgium. With an impressive portfolio of nine patents, Talaga has significantly contributed to the field of pharmaceuticals, particularly in the treatment of neurological disorders. His dedication to innovation has led to the development of novel compounds that hold promise for therapeutic applications.

Latest Patents

Talaga's latest innovations include two noteworthy patents. The first is centered around "2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses." This invention addresses 2-oxo-1-pyrrolidine derivatives represented by a specific formula, showcasing their utility as pharmaceuticals capable of treating neurological disorders, such as epilepsy.

The second patent involves "compounds comprising an oxazoline or thiazoline moiety, processes for making them, and their uses." This invention outlines compounds that function as H-receptor ligands, detailing their chemical structure and potential pharmaceutical applications. These advancements reflect Talaga's commitment to addressing complex medical challenges through innovative chemical solutions.

Career Highlights

Throughout his career, Patrice Talaga has made impactful strides in pharmaceutical research and development. He has worked with notable companies such as UCB S.A. and UCB Pharma S.A., contributing his expertise in medicinal chemistry and formulations. His work has led to the advancement of drug candidates that stand to improve patient care and treatment outcomes in various neurological conditions.

Collaborations

In his professional journey, Talaga has collaborated with esteemed colleagues, including Edmond Differding and Alain Matagne. These partnerships have been integral in fostering a collaborative research environment, allowing for the sharing of insights and expertise that enhance innovation in pharmaceutical development.

Conclusion

Patrice Talaga exemplifies the spirit of innovation in the pharmaceutical industry. His contributions, evidenced by his array of patents and collaborative efforts, mark him as a key figure in the fight against neurological disorders. As the field continues to evolve, inventions like those developed by Talaga will play a crucial role in improving the quality of life for patients worldwide.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.